Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients

  • Reyes-Leiva, David|||0000-0001-6983-7130
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Mayos, Merce|||0000-0003-3972-3671
  • Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
  • Llauger, Jaume|||0000-0002-3744-3257
  • Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
  • Pedrosa Hernández, Irene
  • Segovia, Sonia
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
Objectives: Pompe disease is a rare genetic disease produced by mutations in the GAA gene leading to progressive skeletal and respiratory muscle weakness. T1-weighted magnetic resonance imaging is useful to identify fatty replacement in skeletal muscles of late-onset Pompe disease (LOPD) patients. Previous studies have shown that replacement by fat correlates with worse results of muscle function tests. Our aim was to investigate if fat replacement of muscles involved in the ventilation process correlated with results of the spirometry and predicted respiratory muscle impairment in LOPD patients over time. Materials and Methods: We studied a cohort of 36 LOPD patients followed up annually in our center for a period of 4 years. We quantified muscle fat replacement using Mercuri score of the thoracic paraspinal and abdominal muscles and the pillars of the diaphragm. We correlated the combined Mercuri scores of these areas with spirometry results and the need of respiratory support. Results: We found a statistically significant correlation (Spearman test, p < 0.05; coefficient of correlation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies

  • Alonso-Jiménez, Alicia|||0000-0002-2200-9255
  • Fernández Simón, Esther|||0000-0003-4804-6553
  • Natera-de Benito, Daniel|||0000-0001-7764-2085
  • Ortez González, Carlos Ignacio|||0000-0001-8187-8103
  • García, Carme
  • Montiel Morillo, Elena
  • Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
  • Pedrosa Hernández, Irene
  • Segovia, Sonia
  • Piñol-Jurado, Patricia|||0000-0002-2757-5758
  • Carrasco-Rozas, Ana|||0000-0003-2165-8162
  • Suárez Calvet, Xavier|||0000-0002-5314-6607
  • Jiménez Mallebrera, Cecilia|||0000-0001-8203-7103
  • Nascimento, Andrés
  • Llauger, Jaume|||0000-0002-3744-3257
  • Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
  • Montesinos, Paula|||0000-0001-6944-7730
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Gallardo, Eduard|||0000-0002-3942-3436
  • Illa, Isabel|||0000-0002-2186-2684
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
Introduction: Duchenne (DMD) and Becker (BMD) muscular dystrophy are X-linked muscular disorders produced by mutations in the DMD gene which encodes the protein dystrophin. Both diseases are characterized by progressive involvement of skeletal, cardiac, and respiratory muscles. As new treatment strategies become available, reliable biomarkers and outcome measures that can monitor disease progression are needed for clinical trials. Methods: We collected clinical and functional data and blood samples from 19 DMD patients, 13 BMD patients, and 66 healthy controls (8 pediatric and 58 adult controls), and blood samples from 15 patients with dysferlinopathy (DYSF) and studied the serum concentration of 4 growth factors involved in the process of muscle fibrosis. We correlated the serum concentration of these growth factors with several muscle function tests, spirometry results and fat fraction identified by quantitative Dixon muscle MRI. Results: We found significant differences in the serum concentration of Platelet Derived Growth Factor-AA (PDGF-AA) between DMD patients and pediatric controls, in Connective Tissue Growth Factor (CTGF) between BMD patients and adult controls, and in and Transforming Growth Factor- β1 (TGF-β1) between BMD and DYSF patients. PDGF-AA showed a good correlation with several muscle function tests for both DMD and BMD patients and with thigh fat fraction in BMD patients. Moreover, PDGF-AA levels were increased in muscle biopsies of patients with DMD and BMD as was demonstrated by immunohistochemistry and Real-Time PCR studies. Conclusion: Our study suggests that PDGF-AA should be further investigated in a larger cohort of DMD and BMD patients because it might be a good biomarker candidate to monitor the progression of these diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease

  • Alonso-Jiménez, Alicia|||0000-0002-2200-9255
  • Nuñez Peralta, Claudia Alejandra|||0000-0002-3235-0799
  • Montesinos, Pau|||0000-0002-3275-5593
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • García Sánchez, Carmen|||0000-0001-5672-9229
  • Montiel Morillo, Elena
  • Belmonte Jimeno, Izaskun|||0000-0003-0930-6586
  • Pedrosa Hernández, Irene
  • Segovia, Sonia
  • Llauger, Jaume|||0000-0002-3744-3257
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
Quantitative MRI is an increasingly used method to monitor disease progression in muscular disorders due to its ability to measure changes in muscle fat content (reported as fat fraction) over a short period. Being able to objectively measure such changes is crucial for the development of new treatments in clinical trials. However, the analysis of the images involved continues to be a daunting task because of the time needed. Whether a more specific analysis selecting individual muscles or a global one analyzing the whole thigh or compartments could be a suitable alternative has only been marginally studied. In our study we compare three methods of analysis of 2-point-dixon images in a cohort of 34 patients with late onset Pompe disease followed over a period of one year. We measured fat fraction on MRIs obtained at baseline and at year 1, and we calculated the increment of fat fraction. We correlated the results obtained with the results of muscle function tests to investigate whether the three methods of analysis were equivalent or not. We observed significant differences between the three methods in the estimation of the fat fraction at both baseline and year 1, but no difference was found in the increment in fat fraction between baseline and year 1. When we correlated the fat fraction obtained with each method and the muscle function tests, we found a significant correlation with most tests in all three methods, although in most comparisons the highest correlation coefficient was found with the analysis of individual muscles. We conclude that the fastest strategy of analysis assessing compartments or the whole thigh could be reliable for certain cohorts of patients where the variable to study is the fat increment. In other sorts of studies, an individual muscle approach seems the most reliable technique.